13.56  0.06 (0.44%)		06-09 16:00
Open: 13.53 High: 13.66 Volume: 484,624		Pre. Close: 13.5 Low: 13.46 Market Cap: 825(M)

Short term
Mid term
Targets	6-month :	16.32	1-year :	16.85
Resists	First :	13.97	Second :	14.43
Pivot price	13.73
Supports	First :	13.25	Second :	11.02
MAs	MA(5) :	13.54	MA(20) :	13.79
	MA(100) :	14.08	MA(250) :	14.39
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	21.7	D(3) :	23.2
RSI	RSI(14): 42.7
52-week	High :	16.73	Low :	12.72

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ INMD ] has closed above bottom band by 28.1%. Bollinger Bands are 50.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	13.68 - 13.76	13.76 - 13.83
Low:	13.26 - 13.36	13.36 - 13.45
Close:	13.41 - 13.56	13.56 - 13.69

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.

Thu, 04 Jun 2026
InMode Ltd. (INMD) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow (NASDAQ:INMD) 2026-06-04 - Seeking Alpha

Thu, 04 Jun 2026
INMD Stock Chart | INMODE LTD (NASDAQ:INMD) - ChartMill

Thu, 28 May 2026
InMode: My Pick For A Major Turnaround In 2026 And 2027 (NASDAQ:INMD) - Seeking Alpha

Wed, 27 May 2026
Inmode Ltd (INMD) Reports Solid Numbers in a Soft Market - Yahoo Finance

Tue, 26 May 2026
[Form 3] InMode Ltd. Initial Statement of Beneficial Ownership - Stock Titan

Tue, 26 May 2026
InMode (NASDAQ: INMD) CFO lists direct, spousal shares and RSU awards - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	61 (M)
Shares Float	54 (M)
Held by Insiders	11.9 (%)
Held by Institutions	54.4 (%)
Shares Short	3,070 (K)
Shares Short P.Month	3,250 (K)

EPS	1.35
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	10.77
Profit Margin	23.2 %
Operating Margin	12.2 %
Return on Assets (ttm)	6.8 %
Return on Equity (ttm)	13.6 %
Qtrly Rev. Growth	5.3 %
Gross Profit (p.s.)	4.79
Sales Per Share	6.16
EBITDA (p.s.)	1.32
Qtrly Earnings Growth	-30.8 %
Operating Cash Flow	87 (M)
Levered Free Cash Flow	44 (M)

PE Ratio	10.04
PEG Ratio	0.8
Price to Book value	1.25
Price to Sales	2.2
Price to Cash Flow	9.52

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.